Failure of lopinavir-ritonavir (Kaletra)-containing regimen in an antiretroviral-naive patient [4]

AIDS

Volumn 18, Issue 7, 2004, Pages 1084-1085

  Conradie, Francesca ^a   Sanne, Ian ^a   Venter, Willem ^a   Eron, Joseph ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ATORVASTATIN; DIDANOSINE; HYDROXYUREA; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; AXILLARY LYMPH NODE; CASE REPORT; DNA POLYMORPHISM; FEMALE; FOLLICULITIS; FOLLOW UP; GENE MUTATION; HUMAN; LETTER; LYMPHADENOPATHY; LYMPHOCYTE COUNT; LYMPHOMA; NEEDLE BIOPSY; OPPORTUNISTIC INFECTION; PHYSICIAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION; SELF REPORT; TREATMENT FAILURE; TUBERCULOSIS; VIRUS GENE; VIRUS LOAD;

ADULT; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; PYRIMIDINONES; RITONAVIR; TREATMENT FAILURE;

EID: 2342627431     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200404300-00024     Document Type: Letter

References (4)

1. Walmsley S, Bernstien B, King M, Arribas J, Beall G, Ruane P, et al. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med 346:2039-2146.
2. Kempf DJ, Isaacson JD, King MS, Brun SC, Xu Y, Real K, et al. Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. J Virol 2001; 75:7462-7469
3. Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, et al. Drug resistance mutations in HIV-1. Top HIV Med 2003; 11:215-220.
4. Hirsch MS, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society - USA Panel. Clin Infect Dis 2003; 37:113-128.